Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001654954-18-001503
Filing Date
2018-02-14
Accepted
2018-02-14 09:57:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT cambercatb201813g.htm SC 13G/A 62693
2 JOINT FILING AGREEMENT catabasisformg2017ex1file.htm EX-1 4690
  Complete submission text file 0001654954-18-001503.txt   68947
Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LLC (Filed by) CIK: 0001444043 (see all company filings)

EIN.: 421693587 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88910 | Film No.: 18608160
SIC: 2834 Pharmaceutical Preparations